- Home
- STBA vs ANIP Comparison
STBA vs ANIP Comparison
Compare STBA & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STBA
- ANIP
- Stock Information
- Founded
- STBA 1902
- ANIP 2001
- Country
- STBA United States
- ANIP United States
- Employees
- STBA N/A
- ANIP N/A
- Industry
- STBA Major Banks
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- STBA Finance
- ANIP Health Care
- Exchange
- STBA Nasdaq
- ANIP Nasdaq
- Market Cap
- STBA 1.5B
- ANIP 1.2B
- IPO Year
- STBA N/A
- ANIP N/A
- Fundamental
- Price
- STBA $39.36
- ANIP $57.94
- Analyst Decision
- STBA Hold
- ANIP Buy
- Analyst Count
- STBA 1
- ANIP 7
- Target Price
- STBA $41.00
- ANIP $77.33
- AVG Volume (30 Days)
- STBA 166.5K
- ANIP 172.8K
- Earning Date
- STBA 04-17-2025
- ANIP 02-28-2025
- Dividend Yield
- STBA 3.46%
- ANIP N/A
- EPS Growth
- STBA N/A
- ANIP N/A
- EPS
- STBA 3.41
- ANIP N/A
- Revenue
- STBA $383,756,000.00
- ANIP $555,456,000.00
- Revenue This Year
- STBA N/A
- ANIP $25.54
- Revenue Next Year
- STBA $5.82
- ANIP $20.95
- P/E Ratio
- STBA $11.55
- ANIP N/A
- Revenue Growth
- STBA N/A
- ANIP 23.60
- 52 Week Low
- STBA $28.83
- ANIP $52.50
- 52 Week High
- STBA $45.79
- ANIP $70.81
- Technical
- Relative Strength Index (RSI)
- STBA 49.06
- ANIP 46.25
- Support Level
- STBA $39.43
- ANIP $58.37
- Resistance Level
- STBA $40.90
- ANIP $60.54
- Average True Range (ATR)
- STBA 1.46
- ANIP 1.69
- MACD
- STBA -0.01
- ANIP -0.21
- Stochastic Oscillator
- STBA 51.20
- ANIP 20.28
About STBA S&T Bancorp Inc.
S&T Bancorp Inc is a bank holding company. The company operates in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio and Upstate New York. It has one reporting unit, Community Banking. The company provides financial services with retail and commercial banking products, cash management services, trust and brokerage services. The company earns revenue from interest on loans and securities and fees charged for financial services provided to its customers.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.